Conmed (CNMD) FCF Margin (2010 - 2026)
Conmed posted quarterly FCF Margin of 3.34% for Q1 2026, down 842.0% year-on-year from 0.45% in Q1 2025, and down 69.79% on a QoQ basis from 11.05% in Q4 2025.
Conmed (CNMD) has 17 years of FCF Margin data on file, last reported at 3.34% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 842.0% year-over-year to 3.34%; the trailing twelve-month figure through Mar 2026 stood at 9.03% (down 348.0% YoY), and the FY2025 full-year result was 10.98%, down 80.0% from the prior year.
- FCF Margin for Q1 2026 stood at 3.34%, down from 11.05% in the prior quarter.
- Across five years, FCF Margin topped out at 15.76% in Q4 2023 and bottomed at 6.89% in Q4 2022.
- The 5-year median for FCF Margin is 8.67% (2024), against an average of 7.72%.
- The widest annual swing landed in 2022, when FCF Margin slumped 1805 bps; it then soared 2265 bps in 2023.
- A 5-year view of FCF Margin shows it stood at 6.89% in 2022, then jumped by 329 bps to 15.76% in 2023, then retreated by 28 bps to 11.36% in 2024, then slipped by 3 bps to 11.05% in 2025, then plunged by 70 bps to 3.34% in 2026.
- The last three FCF Margin figures came in at 3.34% (Q1 2026), 11.05% (Q4 2025), and 14.35% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn | 3.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.34% |
| Dec 31, 2025 | 11.05% |
| Sep 30, 2025 | 14.35% |
| Jun 30, 2025 | 6.84% |
| Mar 31, 2025 | 11.75% |
| Dec 31, 2024 | 11.36% |
| Sep 30, 2024 | 15.09% |
| Jun 30, 2024 | 11.96% |
| Mar 31, 2024 | 8.67% |
| Dec 31, 2023 | 15.76% |
| Sep 30, 2023 | 13.37% |
| Jun 30, 2023 | 6.97% |
| Mar 31, 2023 | -2.74% |
| Dec 31, 2022 | -6.89% |
| Sep 30, 2022 | 6.97% |
| Jun 30, 2022 | 4.70% |
| Mar 31, 2022 | -1.39% |
| Dec 31, 2021 | 11.17% |
| Sep 30, 2021 | 6.34% |
| Jun 30, 2021 | 12.26% |
| Mar 31, 2021 | 8.27% |
| Dec 31, 2020 | 6.72% |
| Sep 30, 2020 | 13.39% |
| Jun 30, 2020 | 1.13% |
| Mar 31, 2020 | 0.42% |
| Dec 31, 2019 | 13.10% |
| Sep 30, 2019 | 13.58% |
| Jun 30, 2019 | 6.96% |
| Mar 31, 2019 | -3.64% |
| Dec 31, 2018 | 8.23% |
| Sep 30, 2018 | -0.05% |
| Jun 30, 2018 | 8.04% |
| Mar 31, 2018 | 10.51% |
| Dec 31, 2017 | 7.73% |
| Sep 30, 2017 | 5.11% |
| Jun 30, 2017 | 6.64% |
| Mar 31, 2017 | 6.81% |
| Dec 31, 2016 | 4.59% |
| Sep 30, 2016 | 11.90% |
| Jun 30, 2016 | 6.78% |
| Mar 31, 2016 | -10.68% |
| Dec 31, 2015 | 4.54% |
| Sep 30, 2015 | 5.89% |
| Jun 30, 2015 | 3.60% |
| Mar 31, 2015 | 6.04% |
| Dec 31, 2014 | 11.53% |
| Sep 30, 2014 | 6.29% |
| Jun 30, 2014 | 1.76% |
| Mar 31, 2014 | 7.12% |
| Dec 31, 2013 | 11.02% |
| Sep 30, 2013 | 14.02% |
| Jun 30, 2013 | 7.05% |
| Mar 31, 2013 | 0.72% |
| Dec 31, 2012 | 14.10% |
| Sep 30, 2012 | 12.98% |
| Jun 30, 2012 | 10.79% |
| Mar 31, 2012 | 0.62% |
| Dec 31, 2011 | 11.53% |
| Sep 30, 2011 | 18.74% |
| Jun 30, 2011 | 8.24% |
| Mar 31, 2011 | 9.03% |
| Dec 31, 2010 | 10.36% |
| Sep 30, 2010 | -4.79% |